{"id":"W2804373208","doi":"10.1016/j.jacl.2018.05.007","title":"Efficacy, safety, and tolerability of evolocumab in pediatric patients with heterozygous familial hypercholesterolemia: Rationale and design of the HAUSER-RCT study","year":2018,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université de Montréal","funders":"Amgen Canada; REGENXBIO; Sanofi; Amgen","keywords":"Evolocumab; Medicine; Tolerability; Familial hypercholesterolemia; Alirocumab; Randomized controlled trial; PCSK9; Clinical endpoint; Placebo; Internal medicine; Kexin; Adverse effect; Lipoprotein; Cholesterol; Pathology; LDL receptor","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02286258,0.001841753,0.003593908,0.0005389392,0.0007885521,0.001204842,0.000882701,0.002359274,0.00337153],"category_scores_gemma":[0.01971926,0.0008390165,0.003204684,0.0006916008,0.002208402,0.001778971,0.0009152731,0.002239831,0.0005721516],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001009837,"about_ca_system_score_gemma":0.002002757,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004247007,"about_ca_topic_score_gemma":0.0009716377,"domain_scores_codex":[0.9822071,0.01379671,0.001676058,0.0008779853,0.0007908102,0.0006514374],"domain_scores_gemma":[0.9920216,0.003717094,0.001960675,0.001008699,0.0006333319,0.0006585268],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9233681,0.005506958,0.02243,0.00388786,0.008372615,0.0002739023,0.0005825908,0.001073158,0.003222016,0.001837637,0.0006491651,0.02879611],"study_design_scores_gemma":[0.6788366,0.254057,0.03876783,0.001017651,0.01426018,0.0003996289,0.0004609773,0.001085837,0.002596523,0.001821943,0.006588381,0.0001074283],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"protocol","genre_scores_codex":[0.9274307,0.01665554,0.004962421,0.001500281,0.0004391853,0.0420219,0.001943823,0.00006726904,0.00497884],"genre_scores_gemma":[0.9584225,0.002672524,0.007300581,0.0006820837,0.0003582281,0.02934435,0.0005024236,0.0000144095,0.0007030086],"genre_candidate":"protocol","genre_consensus":null,"teacher_disagreement_score":0.02286258,"threshold_uncertainty_score":0.1209103,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04658844641850102,"score_gpt":0.3418543693989348,"score_spread":0.2952659229804338,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}